Polycystin-1 acts as an atypical adhesion GPCR that responds to novel Wnt signaling and mechanical stimuli
Abstract
Mutations in the genes encoding Polycystin-1 and 2 cause autosomal dominant polycystic kidney disease (ADPKD). These proteins’ cellular functions and the mechanisms through which their absence causes disease are unknown. We find that the behavior of the 11 transmembrane domain polycystin-1 protein resembles that of an adhesion G protein-coupled receptor when activated by Wnt ligands. Exposure to Wnt ligands causes shedding of the polycystin-1 N terminal region, exposing a tethered agonist that activates G protein-dependent functions of the membrane-associated C terminal fragment. Activated polycystin-1 communicates through Gα13to activate RhoA, leading in turn to the ROCK-dependent phosphorylation and inactivation of GSK3β. Activated polycystin-1 traffics out of the primary cilium through an arrestin-dependent mechanism, and arrestin involvement is required for signaling to occur. These data elaborate a function for polycystin-1 that is structurally non-canonical and that is directly connected to pathways whose perturbation results in cystic disease.
Summary
The polycystin-1 protein can activate a signaling pathway resembling those employed by non-canonical adhesion G protein coupled receptors, which is induced by Wnt9b binding and which leads to leads to inhibition of the GSK3β kinase and removal of polycystin-1 from the primary cilium.
<fig id="ufig1" position="float" orientation="portrait" fig-type="figure"><caption>Graphical Abstract
PC1 resides at baseline in the primary cilium. PC1 behaves as an aGPCR that responds to Wnt9b and to flow-induced ATP release by departing from the cilium and initiating the inhibition of GSK3β. The schematic diagram presents a model that integrates the findings presented here. Wnt9b binding to the PC1 NTF leads to shedding of the NTF, exposing the tethered agonist to activate the PC1 receptor-mediated signaling cascade, which involves triggering Gα13binding and the subsequent nucleotide exchange and GTP-loading of RhoA. GTP-bound RhoA stimulates the kinase activity of ROCK, which phosphorylates and inhibits GSK3β.
</caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="655326v1_ufig1" position="float" orientation="portrait"/></fig>Related articles
Related articles are currently not available for this article.